About us

PerlSource instructors have Ph.D.s in Molecular Biology, Immunology and Microbiology and have received advanced training in diverse modern biology areas such as Gene therapy, Virology, Genomics and Bioinformatics from organizations such as Cold Spring Harbor Laboratory, MIT, Dana-Farber Cancer Institute, Harvard Medical School and University of Rochester and from major Biopharmaceutical companies such as OSI Pharmaceuticals, Millennium Pharmaceuticals/The Takeda Oncology Company, Applied Biosystems, Wyeth Research and Compound Therapeutics/Adnexus Therapeutics.

Our instructors each have more than 10 years of experience in specialized subjects such as bioinformatics, genomics, pharmacology, drug formulation, knowledge management, healthcare and life science consulting, and technology development.and have peer-reviewed publications in American and European journals. They have been actively involved in analyzing human, mouse, zebrafish and plant genome data for sequence analysis and annotation, functional genomics andfor data mining for new target identification for therapy of cancer, infectious disease and metabolic disorders. This includes research on -

     § Identification of novel targets from druggable protein families
          -- Kinases, Proteases, Histone deacetylases, Acetyltransferases, etc.
     § Deorphanization of G-protein coupled receptors (GPCRs) for cancer & metabolic disease therapeutics
     § Gene expression/dysregulation patterns in HTLV-induced Adult T-Cell Leukemia & HIV/AIDS

Platforms and packages used -

     § Affymetrix GeneChip®
     § Massively Parallel Signature Sequencing (MPSS)
     § TIBCO Spotfire® DecisionSite Analytic Solutions
     § Open source tools, viz., Blast, Clustalw, Genscan, GoMiner, caARRAY, RasMol, and others
     § Sequence databases & resources, viz., GenBank, DDBJ, EMBL, Swiss-Prot, Ensembl, Entrez Gene, etc.

Clients - Our clients include professionals from organizations such as -

§ MIT - Center for Cancer Research (MA) § OSI Pharmaceuticals Inc. (Melville, NY) § Merck Research Laboratories (Rahway, NJ) § H. Lee Moffitt Cancer Center (Florida) § Solvay Pharma (Weesp, The Netherlands) § University of Potsdam (Potsdam, Germany) § Birla Institute of Tech. & Science (Pilani, India)

§ Birlasoft (Mumbai, India)    § Hexaware Technologies (Mumbai, India)    § Hutchison Max Telecom Ltd. (Mumbai, India)    § Indian Inst. of Technology (N. Delhi, India)    § Knowledge Architects Web (Mumbai, India)    § Pitter Polytex Pvt. Ltd. (Calcutta, India)    § Wipro Technologies (Pune, India), etc.

* * *